Document is current
Any future updates will be listed below
-
Authors
Cimflova, Petra https://orcid.org/0000-0001-8058-383X
Singh, Nishita https://orcid.org/0000-0003-3647-0904
Ospel, Johanna M. https://orcid.org/0000-0003-0029-6764
Marko, Martha https://orcid.org/0000-0002-9063-0465
Kashani, Nima https://orcid.org/0000-0002-9752-784X
Mayank, Arnuv
Hanel, Ricardo https://orcid.org/0000-0001-7195-5806
Haussen, Diogo C. https://orcid.org/0000-0003-1884-2196
Bharatha, Aditya
Volders, David https://orcid.org/0000-0003-4074-8702
Heran, Manraj K. S. https://orcid.org/0000-0003-0040-6054
Poppe, Alexandre Y. https://orcid.org/0000-0002-1419-2635
van Adel, Brian
Menon, Bijoy K.
Joshi, Manish
Demchuk, Andrew https://orcid.org/0000-0002-4930-7789
McTaggart, Ryan https://orcid.org/0000-0001-5853-5161
Nogueira, Raul G. https://orcid.org/0000-0003-4532-153X
Rempel, Jeremy L. https://orcid.org/0000-0003-2324-8415
Zerna, Charlotte https://orcid.org/0000-0001-5969-8990
Tymianski, Michael
Hill, Michael D.
Goyal, Mayank https://orcid.org/0000-0001-9060-2109
Almekhlafi, Mohammed A. https://orcid.org/0000-0001-9550-8197
- License Information
-
More Information
Article History
Received: 11 August 2021
Accepted: 8 November 2021
First Online: 7 January 2022
Declarations
:
: Financial interests: J.M. Ospel received funds from the University of Basel Research Foundation, Julia Bangerter Rhyner Foundation, Freiwillige Akademische Gesellschaft Basel. A.Y. Poppe received research grant from Stryker for EASI-TOC study. B.K. Menon has shares in Circle NVI; patent for systems of triage in acute stroke. A. Demchuk received grants from NoNO; fees from Medtronic; patent Circle NVI. R.G. Nogueira received fees/compensation from Stryker, Medtronic, Cerenovus/Neuravi, Phenox, Anaconda, Genentech, Biogen, Prolong Pharmaceuticals, Brainomix, Viz.ai, Corindus Vascular Robotics, Vesalio, and Ceretrieve. M. Tymianski is CEO of NoNO; patents owned by NoNO. M.D. Hill received grants from Canadian Institutes for Health Research, Alberta Innovates, NoNO, Heart & Stroke Foundation of Canada, National Institutes of Neurological Disorders and Stroke, Covidien, Boehringer-Ingleheim, Stryker, and Medtronic; fees from Merck; patent for systems of acute stroke diagnosis; a patent issued and licensed to US Patent office Number: 62/086,077; stock in Calgary Scientific. M. Goyal received personal fees from Mentice, Medtronic, Microvention, Stryker; patent to systems of acute stroke diagnosis. Non-financial interests: A.Y. Poppe is PI of EASI-TOC study. B.K. Menon is a member of the editorial board at Stroke (Assistant Editor). A. Demchuk is a member of the editorial board at International Journal of Stroke (Editor). R.G. Nogueira is a member of the Physician Advisory Board for Cerenovus/Neuravi. M.D. Hill is Director, Board of Circle Neurovascular, Director, Board of the Canadian Neuroscience Federation, and Director, Board of the Canadian Stroke Consortium. M. Goyal is a member of the editorial board at Stroke (Consulting Editor). P. Cimflova, N. Singh, M. Marko, N. Kashani, A. Mayank, R. Hanel, D.C. Haussen, A. Bharatha, D. Volders, M.K.S. Heran, B. van Adel, M. Joshi, R. McTaggart, J.L. Rempel, C. Zerna and M.A. Almekhlafi declare that they have no competing interests.
: This study was approved by the local ethics committee of the University of Calgary (ID: ESCAPE-NA1, REB-19-3029). Consent to participate: informed consent was obtained from all individual participants included in the study. Consent for publication: All individual participants have consented to publish data from the study by their agreement to participate in the study.
